KDR and cancer: The promising coumarin derivatives 10, 13 and 15 derivatives against Paca-2, Mel-501, PC-3 and A-375 cancer cell lines were further assessed for their inhibitory activities against EGFR, VEGFR-2 and CDK-2/cyclin A2 kinases to detect their mechanism of action.